Search Results for: Matthew Platkin
New Jersey AG Argues Against Trump Ceasing of Abortions for Servicemembers
New Jersey AG Calls for Meeting on VA Abortion Care Rule
**TRENTON, NJ** – New Jersey Attorney General Matthew J. Platkin has joined a coalition of six attorneys general to request a meeting with the Department of Veterans Affairs (VA) Secretary Doug Collins and Office of Management and Budget (OMB) Director Russell Vought. The purpose of the meeting is to urge the Trump Administration to maintain a federal rule that grants veterans and their families access to important reproductive health services, which includes abortion care.
The “Reproductive Health Services” Rule allows the VA medical benefits package and CHAMPVA to provide abortion counseling and services in cases where the patient’s life or health is at risk or in instances of self-reported rape or incest. The Trump Administration is currently reviewing this rule and has conducted meetings with various stakeholders.
Attorney General Platkin expressed concerns about the potential changes to veterans’ access to reproductive health services, stating the importance of these services for veterans. He highlighted the hardships that could result from blocking access to these crucial medical services, emphasizing the need to prevent any rollback of current regulations.
The attorneys general argue that preserving the rule is vital as it addresses healthcare gaps for veterans and families, especially regarding emergency conditions linked to pregnancy and miscarriage complications.
New Jersey Joins Multi-State $39.1 Million Settlement with Apotex
New Jersey Joins Multi-State $39.1 Million Settlement with Apotex
**TRENTON, NJ** – New Jersey is part of a coalition of 50 states and territories seeking preliminary approval for a $39.1 million settlement with Apotex. The settlement addresses allegations of conspiracy to inflate prices and restrict competition for generic drugs.
Attorney General Matthew J. Platkin, along with a multistate coalition, initially announced the settlement with Apotex last fall, alongside a similar $10 million agreement with Heritage Pharmaceuticals. After securing necessary signatures, the coalition filed a motion for the settlement’s preliminary approval in the U.S. District Court for the District of Connecticut in Hartford.
Consumers who purchased certain generic prescription drugs from May 2009 to December 2019 may be eligible for compensation. To check eligibility, they can call a toll-free number, send an email, or visit the provided website.
Both Apotex and Heritage have agreed to cooperate with ongoing multistate litigation involving 30 corporate defendants and 25 individual executives. The companies will implement internal reforms to ensure compliance with antitrust laws, contributing to the resolution of past infractions and prevention of future misconduct.
